ITGAX and neoplasm: These studies demonstrate that in addition to their APC function, CD11c+ cells are able to switch to subpopulations that exhibit immune suppression and tumor growth stimulation in the tumor environment as a result of metabolic reprogramming and PD-L1 and CSF1R upregulation.